Leukocyte mobilization induced by hypervolemia is due to a combined alpha- and beta-adrenoceptor activation.
A phenomenon of leukocytosis induced by hypervolemic stress was discovered. Although a single injection of 350 microl of saline (equivalent to approx. 70 ml in humans, 1 ml/kg of body weight) did not have an effect on the leukocyte counts in long-term intravenously cannulated, freely behaving rats, a single injection of 750 microl of saline (equivalent to approx. 150 ml in humans, 2.1 ml/kg) induced rapid leukocytosis of 160% within 1 minute followed by a gradual increase up to 180% after 1 hour. Measurement of serum norepinephrine concentration revealed a significant increase in rats of the hypervolemic group, compared with those of the low volume group. Pretreatment with either the beta-adrenoceptor antagonist nadolol or the selective alpha2-adrenoceptor antagonist yohimbine prevented both leukocyte peaks in the high volume group, suggesting a combined receptor activation. This critical dependence of leukocyte counts on changes in blood volume should be taken into consideration in experiments with laboratory animals (the quantity of volume applications can falsify results of experiments).
Nave
H
H
Department of Functional and Applied Anatomy, Medical School of Hannover, Germany.
von Hörsten
S
S
Brabant
G
G
Helfritz
F
F
Drube
J
J
Pabst
R
R
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D007958:Leukocyte Count / Q000662:veterinary; D007962:Leukocytes / Q000276:immunology*; D008297:Male; D009248:Nadolol / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood; D051381:Rats; D011917:Rats, Inbred Lew / Q000276:immunology*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D012965:Sodium Chloride / Q000008:administration & dosage; D013047:Specific Pathogen-Free Organisms; D013312:Stress, Physiological / Q000209:etiology / Q000276:immunology / Q000662:veterinary*; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D015016:Yohimbine; D009248:Nadolol; D012965:Sodium Chloride; D009638:Norepinephrine